![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Association Between Early Virologic Response and Immunologic Outcomes in Raltegravir-treated Patients
|
|
|
Reported by Jules Levin
CROI 2013
C. Tsoukas1, A. Rodgers2, H. Teppler2, R. Leavitt2, B-Y. Nguyen2, P. Sklar2
1McGill University, Montreal, Canada; 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA
![CROI1.gif](../images/031313/031313-3/CROI1.gif)
![CROI2.gif](../images/031313/031313-3/CROI2.gif)
![CROI3.gif](../images/031313/031313-3/CROI3.gif)
![CROI4.gif](../images/031313/031313-3/CROI4.gif)
![CROI5.gif](../images/031313/031313-3/CROI5.gif)
![CROI6.gif](../images/031313/031313-3/CROI6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|